• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过测量双氯芬酸门静脉血浓度差异评估肠肝循环中肠道对门静脉系统的吸收情况。

Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

作者信息

Tabata K, Yamaoka K, Fukuyama T, Nakagawa T

机构信息

Faculty of Pharmaceutical Science, Kyoto University, Japan.

出版信息

Pharm Res. 1995 Jun;12(6):880-3. doi: 10.1023/a:1016217221977.

DOI:10.1023/a:1016217221977
PMID:7667194
Abstract

PURPOSE

We evaluated the first-pass effects in vivo by the intestine and liver during enterophepatic circulation (EHC) by simultaneously measuring the portal and venous plasma concentrations of the rat.

METHODS

The venous and upper portal blood vessels were cannulated through the jugular and the pyloric veins, respectively, to obtain simultaneously blood samples from both sites. After diclofenac was injected as a bolus through the jugular vein, the concentrations of diclofenac in the portal and jugular veins were measured at time intervals. The absorption rate from the intestinal tract into the portal system was determined using the portal-venous difference in plasma concentrations of diclofenac, considering 40% partitioning of diclofenac into erythrocytes.

RESULTS

After one hour, the plasma concentration in the portal vein was always higher than that in the jugular vein in awakening rats with intact EHC (portal-venous blood concentration difference). No portal-venous difference was observed in awakening rats with bile-duct cannulation. Therefore, it was concluded that this portal-venous concentration difference was not due to the hepatic clearance but to diclofenac reabsorption from the intestinal tract.

CONCLUSIONS

Approximately 40% of the dose of diclofenac was reabsorbed over 8 hours from the intestinal tract into the portal system. By comparing the reabsorbed amounts in the portal system and in the systemic circulation, the hepatic extraction ratio in vivo (FH) of diclofenac was estimated to be 63%.

摘要

目的

通过同时测量大鼠门静脉和静脉血浆浓度,评估肠肝循环(EHC)过程中肠道和肝脏在体内的首过效应。

方法

分别通过颈静脉和幽门静脉插管至静脉和上门静脉血管,以同时从两个部位采集血样。经颈静脉快速推注双氯芬酸后,定期测量门静脉和颈静脉中双氯芬酸的浓度。考虑到双氯芬酸40%分布于红细胞中,利用双氯芬酸血浆浓度的门静脉-静脉差值来确定从肠道吸收进入门静脉系统的速率。

结果

1小时后,在具有完整EHC的清醒大鼠中,门静脉中的血浆浓度始终高于颈静脉中的血浆浓度(门静脉-静脉血浓度差值)。在胆管插管的清醒大鼠中未观察到门静脉-静脉差值。因此,得出结论,这种门静脉-静脉浓度差值并非由于肝脏清除,而是由于双氯芬酸从肠道重吸收。

结论

双氯芬酸剂量的约40%在8小时内从肠道重吸收进入门静脉系统。通过比较门静脉系统和体循环中的重吸收量,双氯芬酸在体内的肝提取率(FH)估计为63%。

相似文献

1
Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.通过测量双氯芬酸门静脉血浓度差异评估肠肝循环中肠道对门静脉系统的吸收情况。
Pharm Res. 1995 Jun;12(6):880-3. doi: 10.1023/a:1016217221977.
2
Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Accelerative effect of bile on intestinal absorption of diclofenac.清醒大鼠口服双氯芬酸后利用门静脉-静脉浓度差研究药物在门静脉系统的局部吸收动力学。胆汁对双氯芬酸肠道吸收的促进作用。
Drug Metab Dispos. 1996 Feb;24(2):216-20.
3
Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference.利用门静脉浓度差研究清醒大鼠肠道中左氧氟沙星向门静脉的局部吸收动力学。
Pharm Res. 1996 Aug;13(8):1201-4. doi: 10.1023/a:1016012203496.
4
A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.一种用于大鼠双氯芬酸肠肝循环处置动力学的新分析方法。
Drug Metab Dispos. 1994 May-Jun;22(3):479-85.
5
A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.一种通过测量门静脉和体循环血液浓度差异来建立肝肠循环的再循环模型。
J Pharmacokinet Pharmacodyn. 2003 Apr;30(2):119-44. doi: 10.1023/a:1024415730100.
6
Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.联合给予尿苷对清醒大鼠肠道中5'-脱氧-5-氟尿苷首过代谢的影响——通过门脉-体循环浓度差法进行的评估
Pharm Res. 1998 Jul;15(7):1007-11. doi: 10.1023/a:1011917824836.
7
Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.在一只清醒大鼠中通过短期重复给药利用门脉-体循环浓度差同时评估5-氟尿嘧啶的肠道吸收和肝脏摄取。
Biol Pharm Bull. 1997 Dec;20(12):1313-6. doi: 10.1248/bpb.20.1313.
8
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.环丙沙星阻断了双氯芬酸的肠肝循环,并部分通过抑制肠道β-葡萄糖醛酸酶活性减轻了大鼠非甾体抗炎药诱导的肠病。
Acta Pharmacol Sin. 2016 Jul;37(7):1002-12. doi: 10.1038/aps.2016.54. Epub 2016 May 16.
9
Short-period double-dosing for simultaneous evaluation of intestinal absorption and hepatic disposition in a single conscious rat using cephalexin as test drug.以头孢氨苄为受试药物,在清醒大鼠个体中采用短周期双倍给药法同时评估肠道吸收和肝脏处置情况。
J Pharm Pharmacol. 1997 Dec;49(12):1189-94. doi: 10.1111/j.2042-7158.1997.tb06068.x.
10
Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference.
J Pharm Pharmacol. 1999 May;51(5):585-9. doi: 10.1211/0022357991772682.

引用本文的文献

1
Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac.物种和组织差异对双氯芬酸体外葡萄糖醛酸化的影响。
Molecules. 2024 Dec 12;29(24):5867. doi: 10.3390/molecules29245867.
2
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs.用于评估P-糖蛋白对药物肠道吸收影响的P-糖蛋白抑制剂的特性分析
Pharmaceutics. 2021 Mar 15;13(3):388. doi: 10.3390/pharmaceutics13030388.
3
Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in mice.

本文引用的文献

1
Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
J Pharmacol Exp Ther. 1993 May;265(2):731-8.
2
Physiological parameters in laboratory animals and humans.实验动物和人类的生理参数。
Pharm Res. 1993 Jul;10(7):1093-5. doi: 10.1023/a:1018943613122.
3
A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.一种用于大鼠双氯芬酸肠肝循环处置动力学的新分析方法。
Drug Metab Dispos. 1994 May-Jun;22(3):479-85.
采用小鼠门腔系统血药浓度差模型评价 BCRP 对多种药物肠道吸收的贡献。
Pharmacol Res Perspect. 2020 Jan 17;8(1):e00544. doi: 10.1002/prp2.544. eCollection 2020 Feb.
4
Impact of P-Glycoprotein on Intestinal Absorption of an Inhibitor of Apoptosis Protein Antagonist in Rats: Mechanisms of Nonlinear Pharmacokinetics and Food Effects.P-糖蛋白对大鼠凋亡蛋白抑制剂肠道吸收的影响:非线性药代动力学和食物效应的机制。
Pharm Res. 2018 Aug 13;35(10):190. doi: 10.1007/s11095-018-2470-x.
5
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.环丙沙星阻断了双氯芬酸的肠肝循环,并部分通过抑制肠道β-葡萄糖醛酸酶活性减轻了大鼠非甾体抗炎药诱导的肠病。
Acta Pharmacol Sin. 2016 Jul;37(7):1002-12. doi: 10.1038/aps.2016.54. Epub 2016 May 16.
6
Investigating the barriers to bioavailability of macrolide antibiotics in the rat.
Eur J Drug Metab Pharmacokinet. 2012 Sep;37(3):163-71. doi: 10.1007/s13318-011-0074-5. Epub 2011 Nov 24.
7
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.双氯芬酸和罗非昔布在大鼠体内肠肝循环的群体药代动力学建模
Br J Pharmacol. 2008 Mar;153(5):1072-84. doi: 10.1038/sj.bjp.0707643. Epub 2008 Jan 14.
8
Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.基于器官清除率、循环和分形概念的高级药代动力学模型。
AAPS J. 2007 Jun 29;9(2):E268-83. doi: 10.1208/aapsj0902030.
9
Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat.药物释放速率对治疗效果的影响:双氯芬酸在大鼠胃肠道毒性的制剂依赖性
Inflammopharmacology. 2004;12(1):69-80. doi: 10.1163/156856004773121383.
10
A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.一种通过测量门静脉和体循环血液浓度差异来建立肝肠循环的再循环模型。
J Pharmacokinet Pharmacodyn. 2003 Apr;30(2):119-44. doi: 10.1023/a:1024415730100.
4
Disposition and enterohepatic circulation of diclofenac in dogs.双氯芬酸在犬体内的处置及肝肠循环
Arzneimittelforschung. 1980;30(10):1650-3.
5
Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.门腔静脉转位术后犬体内普萘洛尔的胃肠道代谢缺乏。
J Pharmacol Exp Ther. 1982 May;221(2):512-5.
6
A technique to study hepatic and intestinal drug metabolism separately in the dog.一种在犬体内分别研究肝脏和肠道药物代谢的技术。
J Pharmacol Exp Ther. 1982 May;221(2):507-11.
7
Enterohepatic circulation of clioquinol in the rat.氯碘羟喹在大鼠体内的肠肝循环。
J Pharmacobiodyn. 1984 Jun;7(6):420-5. doi: 10.1248/bpb1978.7.420.
8
Solvent drag in jejunal absorption of salicylic acid and antipyrine obtained by in situ single-pass perfusion method in rat.通过大鼠原位单通道灌注法获得的水杨酸和安替比林在空肠吸收中的溶剂拖曳作用。
J Pharmacobiodyn. 1984 Apr;7(4):246-53. doi: 10.1248/bpb1978.7.246.
9
Influence of the route of administration on the area under the plasma concentration-time curve.给药途径对血浆浓度-时间曲线下面积的影响。
J Pharm Sci. 1969 Jan;58(1):71-5. doi: 10.1002/jps.2600580114.
10
Influence of first-pass effect on availability of drugs on oral administration.首过效应对口服给药时药物可利用度的影响。
J Pharm Sci. 1971 Sep;60(9):1338-40. doi: 10.1002/jps.2600600909.